SABS · SAB Biotherapeutics, Inc. · Webcasts, Transcripts & Audio
$3.16
+0.09 (+2.93%)
At close · Oct 28
Return incl. dividend (before tax)
Q2 2026 earnings call transcript
Market Cap
$285.96M
Shares
90.99M
Volume · Oct 28
81.26K
Avg daily vol (3M)
528.92K
SAB Biotherapeutics, Inc. Webcasts
Earnings calls, investor updates, investor days and conferences for SAB Biotherapeutics, Inc. (SABS), with available transcripts, audio replays and slides. Earnings calls also include available highlights, earnings releases and periodic filings.
Pull transcripts and briefs through the earnings call transcript API or MCP →
Add these events to your calendar (.ics)
Conference
Investor event
2026-10-20
SAB Biotherapeutics, Inc. (SABS) October 20, 2026 Conference Transcript
No reported result — non-financial event
Audio
Transcript
Slides
Conference
Investor event
2026-09-10
SAB Biotherapeutics, Inc. (SABS) September 10, 2026 Conference Transcript
No reported result — non-financial event
Audio
Transcript
Slides
Earnings call
FY26 · Q2
2026-08-06
SAB Biotherapeutics, Inc. (SABS) Q2 2026 Earnings Call Transcript
Confident tone
Safeguard Phase 2b enrollment progress
PRIZE investigator-led Phase 3 study
SAB142 lead asset and mechanism
Diluted EPS
$-0.28
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Conference
Investor event
2026-03-09
SAB Biotherapeutics, Inc. (SABS) March 9, 2026 Conference Transcript
No reported result — non-financial event
Audio
Transcript
Slides
Conference
Investor event
2026-02-25
SAB Biotherapeutics, Inc. (SABS) February 25, 2026 Conference Transcript
No reported result — non-financial event
Audio
Transcript
Slides
Showing 1–5 of 5 webcasts